Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Molbio Diagnostics has raised Rs 281 crore in its IPO anchor round with investments from the World Bank's IFC and HDFC AMC. This backing signifies strong institutional support for the company ahead of its public offering.
PRIVATEAug 09, 2026•about 4 hours ago
Amount Raised
₹2.81 Billion
Round Type
Post-IPO Equity
GoaBiotechnologyHealth Diagnostics
Investors
Motilal Oswal Value Migration FundWhiteoak Capital India Opportunities FundNeo Markets Services Private LimitedNeo Secondaries FundNeo Prime Fund3 P India Equity Fund 1360 One Equity Opportunity Fund Series 4360 One Equity Opportunity FundMotilal Oswal Private EquityTemasekHdfc Mutual FundWorld Bank's Ifc
Description
Molbio Diagnostics, based in Goa, secured Rs 281 crore from anchor investors led by HDFC Mutual Fund, which contributed Rs 35 crore. The IPO opens for subscription on August 10. The investment represents a significant endorsement for Goa's first unicorn. Other notable investors include the World Bank's IFC, enhancing the company's credibility.
Company Information
Company
Molbio Diagnostics
Location
Goa, India
About
Molbio Diagnostics is a Goa-based company specializing in point-of-care diagnostics. It is recognized as Goa's first unicorn and has notable backing from investors like Temasek and Motilal Oswal Private Equity. The company is preparing for an IPO and is focused on expanding its presence in the diagnostics sector. Molbio aims to enhance its infrastructure for research and development.
Predictive Intelligence
Strategic
ML-powered predictions for Molbio Diagnostics's next move
GoaBiotechnologyHealth Diagnostics